Blue Sky Biotech, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Blue Sky Biotech, Inc. - overview
Established
2003
Location
Worcester, MA, US
Primary Industry
Biotechnology
About
Blue Sky Biotech focuses on developing innovative biotechnological products that provide solutions for health challenges and enhance agricultural productivity, aiming to improve the quality of life and farming practices. Founded in 2003 in Worcester, US, Blue Sky Biotech, Inc. specializes in biotechnology. The company merged with LakePharma, Inc.
in March 2016 as part of an investment strategy by Ampersand Capital Partners. Blue Sky Biotech specializes in the development and commercialization of advanced biotechnological products aimed at addressing significant challenges in health and agriculture. Their core offerings include therapeutic agents for chronic diseases and agricultural biostimulants to enhance crop yields and improve plant health. The company targets a diverse client base, including healthcare institutions and agricultural businesses, primarily in North America and Europe.
Blue Sky Biotech generates revenue through direct sales of its therapeutic and agricultural products to business-to-business partners and end consumers. The company partners with healthcare providers and agricultural distributors to facilitate product distribution. Revenue comes from bulk orders from agricultural firms and subscription models in healthcare settings, with pricing plans tailored to client needs. Blue Sky Biotech plans to expand its product line with new therapeutic and agricultural solutions aimed at launching in 2024.
The company also intends to penetrate markets in Asia and South America by 2025, leveraging recent funding from the merger with LakePharma to support these initiatives.
Current Investors
LakePharma, Inc.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare, Specialty Pharmaceuticals
Website
www.blueskybiotech.com
Company Stage
Merged
Total Amount Raised
Subscriber access only
Blue Sky Biotech, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Blue Sky Biotech, Inc. | - | ||||||||
| Growth | Completed | Blue Sky Biotech, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.